Purchase Order 75N93019P00391
Award Date 3/18/19
Potential Completion Date 6/2/19
Potential Value $50K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20878, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), awarded a one-year, firm-fixed-price purchase order to Maxcyte, Inc. for the lease of one MaxCyte® GT Flow Transfection System, valued at $100,000.00. The equipment will be used to support biomedical research at the agency's facilities in Bethesda, Maryland. This award is not associated with a larger contract vehicle and does not utilize a set-aside designation. Maxcyte, Inc. is...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $49,710 purchase order to Maxcyte, Inc. of Potomac, Maryland under a firm fixed price contract. The contract is for the delivery of a Maxcyte E-ATX Cell Processor to support the NIH/NIAID's research efforts through September 15, 2023. As the prime contractor, Maxcyte will provide its cell processing equipment without support from major subcontractors. The...
- This is a federal contract award by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Maxcyte, Inc. for a Transfection System. The contract has a firm fixed price of $81,385.00 and was awarded on August 8, 2018 with a completion date of September 7, 2018. The award was made without a set-aside. Maxcyte, Inc. is a commercial cell engineering company that has previously provided specialized laboratory equipment...
- The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $59,500 purchase order to Maxcyte, Inc. to acquire a MaxCyte ATX Scalable Transfection System, along with processing assemblies and software licenses. The non-competitive award was justified as Maxcyte's proprietary electroporation technology is necessary to allow for the manipulation of transcription factor protein expression. The purchase...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a commercial cell engineering company. The $24,200.00 contract is for the provision of MAXCYTE PROCESSING ASSEMBLIES. Maxcyte has previously held prime federal contracts with agencies like NIH, the Food and Drug Administration, and Department of Veterans Affairs to deliver specialized...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a leading commercial cell engineering company, for the delivery of a PROCESSING ASSEMBLY, CL-1.1 3.5-ML (REAGENTS). The firm fixed price contract, with a potential value of $12,130.00, has an award date of February 15, 2019 and a completion date of April 19, 2019. There was no set-aside used for this contract...
- The National Institutes of Health Clinical Center, within the Department of Health and Human Services, awarded a $126.3K firm fixed-price purchase order to Maxcyte, Inc. for the procurement and installation of a MaxCyte ExPERT GTx Electroporation Device along with Installation Qualification and Operational Qualification (IQ/OQ) services. The contract, awarded on March 24, 2026, with completion targeted for April 23, 2026, will be performed at the NIH Clinical Center in Bethesda, Maryland. This...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Maxcyte, Inc. for a MAXCYTE ATX Electroporation System valued at $40,000 on August 28, 2019. Performance will take place in Gaithersburg, Maryland, with an ultimate completion date of September 1, 2020. The procurement was issued under firm fixed-price terms with no small business set-aside. The order originated from a special notice posted August 22, 2019.</p>
- The National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, awarded a $55,200.00 firm fixed price purchase order to Maxcyte, Inc., a for-profit corporate entity based in Rockville, Maryland. The contract is for the procurement of an EXPERT ATX Electroporation Platform, Generation 3 with accessories, to be used for developing gene editing tools for in vivo gene therapy research. This specialized laboratory equipment supports the agency's...
- The U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $114,087.00 firm fixed-price purchase order to Maxcyte, Inc., a small business company, for the provision of an electroporator and scalable transfection system. This contract supports the FDA's biomedical research and regulatory missions, as Maxcyte has provided similar specialized laboratory equipment and technologies, such as cell processing systems, electroporation and scalable transfection...